Οδηγίες για εμβολιασμό κατά του ιού Η1Ν1.

[k0st]

Λοιπόν, μόλις εγκρίθηκαν τα εμβόλια κατά της γρίπης των χοίρων. Επειδή επικρατεί ακόμα αρκετή σύγχυση γύρω από το θέμα του εμβολιασμού, θεώρησα καλό να παραθέσω εδώ τις οδηγίες που δίνουν τα Centers for Disease Control & Prevention, όσον αφορά στις ομάδες ατόμων για τις οποίες συνίσταται ο εμβολιασμός. Παραθέτω το κείμενο με δικό μου editing και υπογραμμίσεις και ελπίζω να φανεί χρήσιμο σε κάποιον συνάδελφο:

2009 H1N1 Vaccination Recommendations

With the new H1N1 virus continuing to cause illness, hospitalizations and deaths in the US during the normally flu-free summer months and some uncertainty about what the upcoming flu season might bring, CDC's Advisory Committee on Immunization Practices has taken an important step in preparations for a voluntary 2009 H1N1 vaccination effort to counter a possibly severe upcoming flu season. On July 29, ACIP met to consider who should receive 2009 H1N1 vaccine when it becomes available.

CDC’s Advisory Committee on Immunization Practices (ACIP), a panel made up of medical and public health experts, met July 29, 2009, to make recommendations on who should receive the new H1N1 vaccine when it becomes available. While some issues are still unknown, such as how severe the flu season, the ACIP considered several factors, including current disease patterns, populations most at-risk for severe illness based on current trends in illness, hospitalizations and deaths, how much vaccine is expected to be available, and the timing of vaccine availability.

The groups recommended to receive the 2009 H1N1 influenza vaccine include:

•Pregnant women because they are at higher risk of complications and can potentially provide protection to infants who cannot be vaccinated;

•Household contacts and caregivers for children younger than 6 months of age because younger infants are at higher risk of influenza-related complications and cannot be vaccinated. Vaccination of those in close contact with infants younger than 6 months old might help protect infants by “cocooning” them from the virus;

•Healthcare and emergency medical services personnel because infections among healthcare workers have been reported and this can be a potential source of infection for vulnerable patients. Also, increased absenteeism in this population could reduce healthcare system capacity;

•All people from 6 months through 24 years of age

•Persons aged 25 through 64 years who have health conditions associated with higher risk of medical complications from influenza.

No shortage of 2009 H1N1 vaccine is expected, but vaccine availability and demand can be unpredictable and there is some possibility that initially, the vaccine will be available in limited quantities. So, the ACIP also made recommendations regarding which people within the groups listed above should be prioritized if the vaccine is initially available in extremely limited quantities. For more information see the CDC press release CDC Advisors Make Recommendations for Use of Vaccine Against 2009 H1N1. Σημείωση: Παραθέτω αμέσως από κάτω τις υπο-ομάδες που έχουν προτεραιότητα σε περίπτωση περιορισμένου αριθμού διαθέσιμων εμβολίων.

CDC press release CDC Advisors Make Recommendations for Use of Vaccine Against 2009 H1N1.

There is some possibility that initially the vaccine will be available in limited quantities. In this setting, the committee recommended that the following groups receive the vaccine before others:

•pregnant women,

•people who live with or care for children younger than 6 months of age,

•health care and emergency medical services personnel with direct patient contact,

•children 6 months through 4 years of age, and

•children 5 through 18 years of age who have chronic medical conditions.

Once the demand for vaccine for the prioritized groups has been met at the local level, programs and providers should also begin vaccinating everyone from the ages of 25 through 64 years. Current studies indicate that the risk for infection among persons age 65 or older is less than the risk for younger age groups. However, once vaccine demand among younger age groups has been met, programs and providers should offer vaccination to people 65 or older.

Σημείωση: Δεν βρήκα πουθενά ακόμη τις Ευρωπαϊκές Οδηγίες (ίσως να μην έχουν ακόμα καθοριστει κιόλας). Αν τις έχει βρει κάποιος παρακαλείται να τις παραθέσει.

Τέλος, ιδού το λινκ για την ιστοσελίδα των CDC: Centers for Disease Control

Αυτά...